Sarepta signs another Duchenne gene therapy pact as it aims for wider treatment – FierceBiotech
FierceBiotech |
Sarepta signs another Duchenne gene therapy pact as it aims for wider treatment
FierceBiotech Sarepta Therapeutics has penned its second DMD gene therapy pact this year as it announces a tie-up with France's Genethon, a nonprofit R&D org. The research collaboration will see the Franco-American pair jointly develop treatments for Duchenne … Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of … |
